Literature DB >> 8068129

Multiple myeloma.

N H Russel, A E Hunter, A Haynes, E M Bessell.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8068129      PMCID： PMC2540610          DOI： 10.1136/bmj.308.6945.1715a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis. The Medical Research Council Working Party for Leukaemia in Adults.

Authors:  I C MacLennan; C Chapman; J Dunn; K Kelly
Journal:  Lancet       Date:  1992-01-25       Impact factor: 79.321

2.  Effective prevention of acute GVHD following allogeneic BMT with low leukaemic relapse using methotrexate and therapeutically monitored levels of cyclosporin A.

Authors:  A E Hunter; E M Bessell; N H Russell
Journal:  Bone Marrow Transplant       Date:  1992-11       Impact factor: 5.483

3.  Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation.

Authors:  G Gahrton; S Tura; P Ljungman; C Belanger; L Brandt; M Cavo; T Facon; A Granena; M Gore; A Gratwohl
Journal:  N Engl J Med       Date:  1991-10-31       Impact factor: 91.245
  3 in total
  1 in total

1.  Allelic loss at 19q12 and Xq11-12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential.

Authors:  K Nakayama; Y Takebayashi; K Hata; R Fujiwaki; K Iida; M Fukumoto; K Miyazaki
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.